Skip to main content
Clinical Trials/NL-OMON38749
NL-OMON38749
Completed
Not Applicable

Peripheral Insulin Uptake in Type 2 Diabetes Mellitus and in Non-Diabetic Individuals - Peripheral Insulin Uptake Study

Kennemer Gasthuis0 sites74 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
diabetes
Sponsor
Kennemer Gasthuis
Enrollment
74
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 13, 2015
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Kennemer Gasthuis

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for all participants:
  • \- written informed consent
  • \- hemodynamically stable with a systolic blood pressure \> 100 mmHg
  • Inclusion criteria for non\-diabetic individuals:
  • \- 30 years \* age \* 80 years (extremes included)
  • \- fasting glucose level of \< 7\.0 mmol/L and HbA1C \< 6\.5% (\<\= \< 48 mmol/mol)
  • Inclusion criteria for T2DM patients:
  • \- 30 years \* age \* 80 years (extremes included)
  • \- fasting glucose level of \> 7\.0 mmol/L, or HbA1C \> 6\.5 (\<\= \> 48 mmol/mol) or known T2DM

Exclusion Criteria

  • Exclusion criteria for all participants:
  • \- ongoing myocardial infarction as determined from elevated cardiac markers
  • \- participation in an investigational trial within 90 days prior to present study
  • \- donation of blood (\> 100 mL) within 90 days prior to present study
  • \- serious mental impairment or language problems i.e. preventing to understand the study protocol/aim
  • \- Use or recent use (within 3 months of study participation) of oral glucocorticoids
  • Exclusion criteria for non\-diabetic individuals:
  • \- known T2DM/use of glucose\-lowering medication
  • Exclusion criteria for T2DM patients:
  • \- treatment with insulin preparations

Outcomes

Primary Outcomes

Not specified

Similar Trials